Lidopac
NDC Package 69336-829-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Lidopac is (Lidocaine Ointment USP, 5%) is indicated for production of anesthesia of accessible mucous membranes of the oropharynx.It is also useful as an anesthetic lubricant for intubation and for the temporary relief of pain associated with minor burns, including sunburn, abrasions of the skin, and insect bites. Marketed by Sterling-knight Pharmaceuticals, Llc, this product is identified by NDC 69336-829 and is authorized under FDA application ANDA206297.

Identification & Billing

NDC Package Code
69336-829-01
Package Description
1 TUBE in 1 CARTON / 35.44 g in 1 TUBE
Product Code
69336-829
11-Digit Billing Format
69336082901
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lidopac
Dosage Form
-
Usage Information
Lidopac (Lidocaine Ointment USP, 5%) is indicated for production of anesthesia of accessible mucous membranes of the oropharynx.It is also useful as an anesthetic lubricant for intubation and for the temporary relief of pain associated with minor burns, including sunburn, abrasions of the skin, and insect bites.

Regulatory & Marketing

Labeler Name
Sterling-knight Pharmaceuticals, Llc
FDA Application #
ANDA206297
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-15-2016
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69336-829-01 identifies a specific commercial package of 1 tube in 1 carton / 35.44 g in 1 tube of Lidopac, labeled by Sterling-knight Pharmaceuticals, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sterling-knight Pharmaceuticals, Llc on August 15, 2016. The current certification is valid through December 31, 2018.

How is this Sterling-knight Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69336082901. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69336-829-01
11-Digit CMS (5-4-2)
69336-0829-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.